<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01067703</url>
  </required_header>
  <id_info>
    <org_study_id>ME 3559/1-1</org_study_id>
    <nct_id>NCT01067703</nct_id>
  </id_info>
  <brief_title>Remote Ischaemic Preconditioning for Heart Surgery (RIPHeart-Study)</brief_title>
  <official_title>Remote Ischaemic Preconditioning for Heart Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Schleswig-Holstein</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Frankfurt</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Schleswig-Holstein</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effects of Remote Ischaemic Preconditioning on
      perioperative ischaemic injury in patients undergoing cardiac surgery compared to control
      intervention.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiac surgery with cardiopulmonary bypass is associated with a predictable incidence of
      myocardial, neurological and renal dysfunction. This significant morbidity and mortality is
      at least partly due to perioperative ischaemia. Remote ischaemic preconditioning (RIPC) is a
      novel, simple, non-invasive and inexpensive intervention by which ischaemia of non-vital
      tissue (skeletal muscles) protects remote organs (heart, brain and kidney) from a subsequent
      sustained episode of ischaemia. The investigators perform a multicenter randomized controlled
      study to evaluate that RIPC reduces teh severity of perioperative ischaemic injury in
      patients undergoing cardiac surgery, and results in about 1/3 risk reduction in the occurence
      of major adverse events.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite of all-cause mortality, non-fatal myocardial infarction, any new stroke, and/or acute renal failure</measure>
    <time_frame>In-hospital</time_frame>
    <description>Time frame until hospital discharge</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Occurence of any component of the composite outcome</measure>
    <time_frame>Postoperative hospital discharge, 3 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of stay on the intensive care unit</measure>
    <time_frame>Postoperative during hospital stay</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>total hospital stay</measure>
    <time_frame>hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>new onset of atrial fibrillation</measure>
    <time_frame>In-hospital</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delirium</measure>
    <time_frame>Postoperative 24, 48, 72, 96 hrs</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1400</enrollment>
  <condition>Myocardial Injury</condition>
  <condition>Mortality</condition>
  <arm_group>
    <arm_group_label>RIPC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>CONTROL</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Remote Ischemic Preconditioning</intervention_name>
    <description>RIPC will be induced during anesthesia by four 5-min cycles of upper limb ischemia and 5-min reperfusion using a blood-pressure cuff inflated to a pressure 200 mm Hg, whereas the pressure has to be at least 20 mm Hg greater than the systolic arterial pressure measured via the arterial line.</description>
    <arm_group_label>RIPC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Control/sham procedure (blood pressure cuff)</intervention_name>
    <description>Sham placement of the blood pressure cuff around a dummy arm inflated to a pressure of 200 mm Hg with four cycles of 5 min inflation and 5 min deflation.</description>
    <arm_group_label>CONTROL</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing heart surgery on cardiopulmonary bypass

        Exclusion Criteria:

          -  age &lt; 18

          -  Emergency cases

          -  left ventricular ejection fraction less than 30%

          -  current atrial fibrillation

          -  Inability to give informed consent

          -  preoperative use of inotropics or mechanical assist device

          -  severe liver, renal and pulmonary disease

          -  recent myocardial infarction (within 7 days)

          -  recent systemic infection or sepsis (within 7 days)

          -  severe stroke (within 2 months)

          -  peripheral vascular disease affecting upper limbs

          -  previous serious psychiatric disorders (e.g. schizophrenia, dementia)

          -  concomitant carotid endarterectomy

          -  rare surgeries: cardiac transplantation, correction of complicated congenital
             anomalies, pulmonary thromboembolectomy, off-pump surgery, minimal-invasive operation
             without sternotomy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrick Meybohm, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Frankfurt/ University Hospital Schleswig-Holstein</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Berthold Bein, MD, DESA</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Schleswig-Holstein</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jochen Cremer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Schleswig-Holstein</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kai Zacharowski, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Frankfurt am Main</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Aachen (RWTH)</name>
      <address>
        <city>Aachen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Charite</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Bonn</name>
      <address>
        <city>Bonn</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Frankfurt/M</name>
      <address>
        <city>Frankfurt/M</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Goettingen</name>
      <address>
        <city>Goettingen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Schleswig-Holstein</name>
      <address>
        <city>Kiel</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Schleswig-Holstein</name>
      <address>
        <city>Luebeck</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Magdeburg</name>
      <address>
        <city>Magdeburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Rostock</name>
      <address>
        <city>Rostock</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Wuerzburg</name>
      <address>
        <city>Wuerzburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Meybohm P, Bein B, Brosteanu O, Cremer J, Gruenewald M, Stoppe C, Coburn M, Schaelte G, Böning A, Niemann B, Roesner J, Kletzin F, Strouhal U, Reyher C, Laufenberg-Feldmann R, Ferner M, Brandes IF, Bauer M, Stehr SN, Kortgen A, Wittmann M, Baumgarten G, Meyer-Treschan T, Kienbaum P, Heringlake M, Schön J, Sander M, Treskatsch S, Smul T, Wolwender E, Schilling T, Fuernau G, Hasenclever D, Zacharowski K; RIPHeart Study Collaborators. A Multicenter Trial of Remote Ischemic Preconditioning for Heart Surgery. N Engl J Med. 2015 Oct 8;373(15):1397-407. doi: 10.1056/NEJMoa1413579. Epub 2015 Oct 5.</citation>
    <PMID>26436208</PMID>
  </results_reference>
  <results_reference>
    <citation>Meybohm P, Zacharowski K, Cremer J, Roesner J, Kletzin F, Schaelte G, Felzen M, Strouhal U, Reyher C, Heringlake M, Schön J, Brandes I, Bauer M, Knuefermann P, Wittmann M, Hachenberg T, Schilling T, Smul T, Maisch S, Sander M, Moormann T, Boening A, Weigand MA, Laufenberg R, Werner C, Winterhalter M, Treschan T, Stehr SN, Reinhart K, Hasenclever D, Brosteanu O, Bein B; RIP Heart-Study Investigator Group. Remote ischaemic preconditioning for heart surgery. The study design for a multi-center randomized double-blinded controlled clinical trial--the RIPHeart-Study. Eur Heart J. 2012 Jun;33(12):1423-6.</citation>
    <PMID>22880214</PMID>
  </results_reference>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 10, 2010</study_first_submitted>
  <study_first_submitted_qc>February 10, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 11, 2010</study_first_posted>
  <last_update_submitted>December 1, 2015</last_update_submitted>
  <last_update_submitted_qc>December 1, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Schleswig-Holstein</investigator_affiliation>
    <investigator_full_name>Patrick Meybohm</investigator_full_name>
    <investigator_title>Prof. Dr. Patrick Meybohm</investigator_title>
  </responsible_party>
  <keyword>remote ischaemic preconditioning, cardiac surgery</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

